EMN
40
5
PHM
44
4
FE
34
4
MKC
54
3
PPL
44
9
NSC
33
6
GRMN
53
3
URBN
67
3
STT
48
4
HCP
54
2
CMI
49
2
JCI
44
7
PLD
35
5
UPS
51
6
PNC
48
6
STZ
42
2
NVDA
52
5
AZO
46
3
LMT
29
-5
LB
16
9
EMN
40
5
PHM
44
4
FE
34
4
MKC
54
3
PPL
44
9
NSC
33
6
GRMN
53
3
URBN
67
3
STT
48
4
HCP
54
2
CMI
49
2
JCI
44
7
PLD
35
5
UPS
51
6
PNC
48
6
STZ
42
2
NVDA
52
5
AZO
46
3
LMT
29
-5
LB
16
9
Financhill
Back

Blueprint Medicines Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
40

BPMC
Blueprint Medicines

Last Price:
$90.24
Seasonality Move:
2.18%
Sell
42

REGN
Regeneron Pharmaceuticals

Last Price:
$701.91
Seasonality Move:
10.8%
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $701.85. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $90.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $701.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: 540770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.73 - 96.57) Sell
Bollinger Bands (100): (87.46 - 96.54) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -29.66 Sell
Relative Strength Index (14 RSI): 27.8 Sell
Chaikin Money Flow: -1643849 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (727.49 - 769.33) Sell
Bollinger Bands (100): (805.13 - 1140.25) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.88 Sell
20-day SMA: 94.44 Sell
50-day SMA: 92.37 Sell
200-day SMA: 96.72 Sell
8-day EMA: 92.45 Sell
20-day EMA: 93.6 Sell
50-day EMA: 93.36 Sell
200-day EMA: 91.74 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 729.36 Sell
20-day SMA: 747.95 Sell
50-day SMA: 826.21 Sell
200-day SMA: 980.92 Sell
8-day EMA: 726.23 Sell
20-day EMA: 750.86 Sell
50-day EMA: 823.81 Sell
200-day EMA: 934.41 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.01 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):